Related Experiment Video
Updated: Jun 5, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations
Michael R Mulvey1, Malcolm Doupe, Michael Prout
1National Microbiology Laboratory, Antimicrobial Resistance and Nosocomial Infections, Winnipeg, Canada.
Background:
Staphylococcus aureus may produce superantigens that can non-specifically activate CD4(+) cells to potentially target the myelin basic protein.
Objective:
This study examined the association between individuals with multiple sclerosis (MS) and colonization with S. aureus harbouring superantigens.
Methods:
Nasal swabs were collected from non-MS subjects and patients with MS who had not experienced a relapse in the past six months (MS stable group) and who had suffered a relapse within 30 days of study recruitment (MS exacerbation group). S. aureus was isolated from the anterior nares of participants following standard procedures and staphylococcal superantigen genes (sea, seb, and tsst-1) were detected using standard laboratory PCR techniques.
Results:
The study enrolled 204 patients, 80 in the non-MS and MS stable groups and 44 patients in the MS exacerbation group. Overall, 27.0% of patients were colonized with S. aureus with no significant differences identified between study groups. Amongst individuals colonized with S. aureus, the prevalence of sea was significantly greater in the MS exacerbation versus non-MS study group (p < 0.05; odds ratio 7.9; 95% confidence interval 1.2-49.5).
Conclusions:
The ability to rapidly screen patients for the presence of S. aureus producing sea may serve as a useful marker of a potential MS exacerbation.
Insights
Staphylococcus aureus colonization, particularly with the sea superantigen, is linked to multiple sclerosis (MS) exacerbations. Screening for S. aureus producing sea may help identify patients at risk for MS relapses.
Area of Science:
- Microbiology
- Immunology
- Neurology
Background:
- Staphylococcus aureus can produce superantigens that activate CD4(+) cells, potentially targeting myelin basic protein.
- This activation may play a role in the pathogenesis of multiple sclerosis (MS).
Purpose of the Study:
- To investigate the association between multiple sclerosis (MS) and colonization with Staphylococcus aureus (S. aureus) carrying superantigens.
- To determine if specific S. aureus superantigens correlate with MS exacerbation.
Main Methods:
- Nasal swabs were collected from individuals without MS, with stable MS, and with MS exacerbation.
- S. aureus was isolated, and the presence of staphylococcal superantigen genes (sea, seb, tsst-1) was detected using PCR.
Main Results:
- Overall S. aureus colonization rates did not differ significantly between groups.
- However, the prevalence of the sea gene was significantly higher in patients experiencing MS exacerbation compared to those without MS (OR 7.9, p<0.05).
Conclusions:
- The presence of S. aureus producing the sea superantigen may serve as a potential biomarker for MS exacerbation.
- Rapid screening for S. aureus sea could aid in identifying patients at risk for multiple sclerosis relapses.
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Multiple Sclerosis l: Introduction
Bacterial Gastroenteritis
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
